Department of Pediatrics
Section of Hematology-Oncology,
Department of Immunology and Department of Medicine
Baylor College of Medicine
Dr. Catherine Bollard’s research interests involve using cytotoxic T cells (CTL) for viral and malignant diseases. Dr. Catherine Bollard is a principal investigator on four clinical trials assessing the safety of adoptively transferred donor-derived virus-specific CTL for the prevention and treatment of viral infection post allogeneic stem cell and cord blood transplant. In addition, she is investigating the utility of this approach using genetically modified virus-specific CTL for the prevention and treatment of viral infection and relapse after transplant. Dr. Catherine Bollard is also evaluating the efficacy of tumor-specific CTL in patients with relapsed EBV positive Hodgkin’s disease and non-Hodgkin Lymphoma and is the PI on four FDA approved studies for the treatment of lymphoma with T cell therapy. Further, she is developing gene therapy strategies to target the cancer stem cell in lymphoma and to counteract tumor immune evasion mechanisms to enhance the efficacy of adoptive immunotherapy protocols. Finally, Dr. Catherine Bollard is exploring the feasibility of expanding T cells targeting non-EBV tumor-associated antigens for the treatment of EBV-negative lymphomas.
Dr. Bollard’s clinical interests are in bone marrow transplantation and cell and gene therapy.
She is on the editorial boards of The Journal of Bone Marrow Transplantation and The Journal of Biology of Blood and Marrow Transplant.
M.B.Ch.B. and M.D., Otago Medical School, New Zealand
Residency and Fellowship, Royal Australasian College of Physicians
Residency and Fellowship, Royal College Pathologists of Australasia
Fellowship, Baylor College of Medicine
Royal Australasian College of Physicians (Pediatrics)
Royal College of Pathologists of Australasia (Hematology)
Member, International Society of Cellular Therapy
Inspector, Foundation for the Accreditation of Cellular Therapy
Member of Hodgkin Disease Committee, Children’s Oncology Group
Member, American Society of Gene Therapy
Member, American Society of Blood and Marrow Transplantation
Member, American Society of Hematology (ASH)
Member, Hematology Society of Australia and New Zealand